BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Clinical trials for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) trials appear
Sign up with your email to follow new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New program aims to protect cancer Patients' hearts during treatment
Disease control Not yet recruitingThis study looks at whether a special program called Primary Care Connect (PC2) helps cancer survivors who also have conditions like high blood pressure, diabetes, or high cholesterol keep their heart risks under control during cancer treatment. About 266 adults with early-stage …
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Freezing, not cutting: new study tests cryoablation for breast cancer in seniors
Disease control Not yet recruitingThis study tests a freezing technique called cryoablation as a main treatment for early-stage breast cancer in adults aged 70 and older. Instead of surgery or long-term hormone pills, doctors use imaging to guide a needle that freezes and destroys the tumor. The goal is to see if…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: St. Antonius Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could two new drugs boost chemo success in HER2-Low breast cancer?
Disease control Not yet recruitingThis phase II trial tests whether adding the drugs SHR-A1811 and/or adebrelimab to standard chemotherapy can improve outcomes for people with HR-positive, HER2-low early-stage breast cancer. About 249 participants will receive either chemo alone, chemo plus adebrelimab, or a sequ…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Radioactive seeds aim to boost Chemo's punch against breast cancer
Disease control Not yet recruitingThis phase 3 trial tests whether placing tiny radioactive seeds in breast tumors before chemotherapy can help eliminate cancer more completely. About 194 women with early or locally advanced breast cancer will either get standard chemo alone or chemo plus seed placement. The goal…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE3 • Sponsor: Pengfei Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could 2 years of hormone therapy be enough for some breast cancers?
Disease control Not yet recruitingThis study tests whether a shorter course of hormone therapy (2-3 years) works as well as the standard longer treatment for women with a very low-risk, early-stage breast cancer. About 2,900 women will be randomly assigned to either the shorter or standard treatment. The goal is …
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 13:35 UTC
-
New scanner could slash repeat breast surgeries
Diagnosis Not yet recruitingThis study tests a new handheld scanner that gives surgeons a real-time, close-up view of the surgical area to see if any cancer cells remain after removing a breast tumor. Current methods can take time and may miss some cancer cells, sometimes requiring a second surgery. The sca…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Sponsor: West China Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Tech trio aims to help breast cancer survivors remember daily pills
Symptom relief Not yet recruitingThis study tests whether a system combining a smartphone app, a special pill bottle that records when it's opened, and a Fitbit can help breast cancer survivors take their long-term hormone therapy more consistently. Fifteen survivors aged 21-70 will use the system for six months…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: San Diego State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New study aims to predict who will respond to breast cancer therapy
Knowledge-focused Not yet recruitingThis study looks at tumor samples from 55 women with early-stage breast cancer to find early signs of whether chemo-immunotherapy is working. By analyzing individual cells before, during, and after treatment, researchers hope to identify markers that predict response or resistanc…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC